Atea Pharmaceuticals, Inc. (AVIR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US04683R1068
Atea Pharmaceuticals, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -180.89 m USD |
| EBIT | -164.51 m USD |
| Net income | -158.35 m USD |
| Diluted EPS – continuing operations | -1.94 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The company also developing AT-587, that is in Phase 1 clinical trial for the treatment of chronic HEV infection. In addition, it offers a proprietary platform of nucleosides and nucleotides for virology, medicinal chemistry, and antiviral drug development. The company has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
More stocks
- Verano Holdings Corp. (VRNO)
- Aduro Clean Technologies Inc. Common Stock (ADUR)
- Tecnon Fujian Commercial Lighting Co Ltd (300650.SZ)
- Zhejiang Huilong New Materials Co.Ltd. (301057.SZ)
- Hana Tour (039130.KS)
- C & F FINANCIAL CORP (CFFI)
- Shandong Hongyu Agricultural Machinery Co Ltd (002890.SZ)
- Nanjing Chervon Auto Precision Technology Co Ltd (603982.SS)
- Guangzhou Jointas Chemical Joint Stock Co Ltd (002909.SZ)
- CHAIN BRIDGE BANCORP INC (CBNA)
- BayCom Corp (BCML)
- Shenzhen Prolto Supply Chain Management Co Ltd (002769.SZ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.